Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast Cancer.

Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast Cancer. Clin Cancer Res. 2015 Nov 15; 21(22):5121-5130.

View in: PubMed

subject areas

Animals
Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 6
Disease-Free Survival
Drug Resistance, Neoplasm
Estradiol
Estrogen Receptor alpha
Female
Gene Expression Regulation, Neoplastic
Humans
MCF-7 Cells
Mice
Mutation
Piperazines
Pyridines
Selective Estrogen Receptor Modulators
Tamoxifen
Xenograft Model Antitumor Assays

authors with profiles

DONALD MCDONNELL